Detalhe da pesquisa
1.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med
; 389(23): 2162-2174, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055253
2.
Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers.
Cancer
; 130(3): 385-399, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751191
3.
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.
Gynecol Oncol
; 182: 51-56, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262238
4.
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Gynecol Oncol
; 183: 103-114, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593674
5.
The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria.
Gynecol Oncol
; 175: 32-40, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321153
6.
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?
Gynecol Oncol
; 177: 46-52, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639902
7.
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.
Gynecol Oncol
; 173: 15-21, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037083
8.
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer.
Gynecol Oncol
; 178: 14-22, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741201
9.
Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient population.
Gynecol Oncol
; 170: 203-209, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709661
10.
Postoperative venous thromboembolism risk stratification in patients with uterine cancer.
Am J Obstet Gynecol
; 228(5): 555.e1-555.e8, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574873
11.
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer.
Am J Obstet Gynecol
; 228(1): 59.e1-59.e13, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931127
12.
Racial Disparities in Surgical Outcomes Among Women with Endometrial Cancer.
Ann Surg Oncol
; 29(13): 8338-8344, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138286
13.
Hospital-based ovarian cancer patient traceback program results in minimal genetic testing uptake.
Gynecol Oncol
; 164(3): 615-621, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34998598
14.
Racial and ethnic disparities in readmission risk following the surgical management of endometrial cancer.
Gynecol Oncol
; 166(3): 543-551, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35882610
15.
The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?
Gynecol Oncol
; 167(2): 174-180, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36154763
16.
Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?
Oncologist
; 26(12): 1044-1051, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34402130
17.
Impact of Molecular Classification on Treatment Paradigms in Uterine Cancers.
Curr Oncol Rep
; 23(7): 75, 2021 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33937919
18.
Where you live matters: A National Cancer Database study of Medicaid expansion and endometrial cancer outcomes.
Gynecol Oncol
; 158(2): 407-414, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527568
19.
Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
Cancer
; 125(3): 398-405, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561762
20.
Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy".
Cancer
; 130(9): 1713-1714, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430468